Results 51 to 60 of about 4,681 (114)

Dual CFTR modulator therapy efficacy in the real world: lessons for the future. [PDF]

ERJ Open Res, 2022
Dittrich AM, Chuang SY.
europepmc   +1 more source

Height Velocity in Pediatric Cystic Fibrosis Under Triple CFTR Modulator Therapy: A Real-Life Monocentric Experience. [PDF]

J Clin Med
Boni A, d'Aniello F, Ubertini G, Cappa M, Ciciriello F, Majo F, Cristiani L, Alghisi F, Montemitro E, Bella S, De Marchis M, Cutrera R, Fiocchi AG.   +12 more
europepmc   +1 more source

Personalized Selection of a CFTR Modulator for a Patient with a Complex Allele [L467F;F508del]. [PDF]

Curr Issues Mol Biol, 2022
Kondratyeva E, Bulatenko N, Melyanovskaya Y, Efremova A, Zhekaite E, Sherman V, Voronkova A, Asherova I, Polyakov A, Adyan T, Kovalskaia V, Bukharova T, Goldshtein D, Kutsev S.   +13 more
europepmc   +1 more source

Building Lay Society Knowledge and Education for Health Technology Assessment and Policy Engagement: Case of CFTR Modulator Access in Brazil. [PDF]

Healthcare (Basel)
de Oliveira VSB, Amaral MB, Camargo M, Lopes-Pacheco M.   +3 more
europepmc   +1 more source

Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis. [PDF]

Pharmaceuticals (Basel), 2023
Bacalhau M, Camargo M, Magalhães-Ghiotto GAV, Drumond S, Castelletti CHM, Lopes-Pacheco M.   +5 more
europepmc   +1 more source

Personalised CFTR Modulator Treatment Initiation and Monitoring in CF-Related Liver Disease: When Less Is More. [PDF]

Respirol Case Rep
Vekaria S, Kavanagh G, Mulrennan S.
europepmc   +1 more source

How Should the Effects of CFTR Modulator Therapy on Cystic Fibrosis Lung Disease Be Monitored? [PDF]

Am J Respir Crit Care Med, 2022
Ben-Meir E, Grasemann H.
europepmc   +1 more source

Innate Immunity in Cystic Fibrosis: Varied Effects of CFTR Modulator Therapy on Cell-to-Cell Communication. [PDF]

Int J Mol Sci
Hynes J, Taggart CC, Tirouvanziam R, Coppinger JA.   +3 more
europepmc   +1 more source

Identification of early changes in multiple biomarkers following CFTR modulator initiation in patients with cystic fibrosis. [PDF]

Ther Adv Respir Dis
Heer P, Fernandez Elviro C, Koutsokera A, Mornand A, Rochat I, Regamey N, Blanchon S.   +6 more
europepmc   +1 more source

Preservation of β-cell Function in Pancreatic Insufficient Cystic Fibrosis With Highly Effective CFTR Modulator Therapy.

J Clin Endocrinol Metab, 2023
Flatt AJ, Sheikh S, Peleckis AJ, Alvarado P, Hadjiliadis D, Stefanovski D, Gallop RJ, Rubenstein RC, Kelly A, Rickels MR.   +9 more
europepmc   +1 more source